Srini Ramanathan
Corporate Officer/Principal at ROIVANT SCIENCES LTD.
Srini Ramanathan active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ROIVANT SCIENCES LTD. | Corporate Officer/Principal | 2022-05-01 | - |
Career history of Srini Ramanathan
Former positions of Srini Ramanathan
| Companies | Position | Start | End |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - | - |
Training of Srini Ramanathan
| Duquesne University School of Law | Graduate Degree |
| Rutgers State University of New Jersey | Doctorate Degree |
Statistics
International
| United Kingdom | 2 |
| Ireland | 2 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ROIVANT SCIENCES LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Srini Ramanathan
- Experience
